Bodycote Receives “Buy” Rating from N+1 Singer (BOY)
Bodycote (LON:BOY)‘s stock had its “buy” rating reaffirmed by analysts at N+1 Singer in a research report issued to clients and investors on Monday, American Banking and Market News reports. They currently have a GBX 700 ($11.48) price target on the stock. N+1 Singer’s price target would indicate a potential upside of 3.09% from the stock’s previous close.
Shares of Bodycote (LON:BOY) opened at 684.50 on Monday. Bodycote has a 52 week low of GBX 440.00 and a 52 week high of GBX 691.00. The stock’s 50-day moving average is GBX 629.9 and its 200-day moving average is GBX 623.. The company’s market cap is £1.296 billion.
BOY has been the subject of a number of other recent research reports. Analysts at Credit Suisse reiterated an “outperform” rating on shares of Bodycote in a research note to investors on Thursday, December 12th. They now have a GBX 760 ($12.47) price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Bodycote in a research note to investors on Friday, November 22nd. They now have a GBX 540 ($8.86) price target on the stock. Finally, analysts at Jefferies Group raised their price target on shares of Bodycote from GBX 605 ($9.92) to GBX 710 ($11.65) in a research note to investors on Wednesday, November 20th. They now have a “buy” rating on the stock. Three research analysts have rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of GBX 644.98 ($10.58).
Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.